Cargando…

Natriuretic Peptide System Activation in Acute Heart Failure Patients with Diabetes

BACKGROUND: Elevated B-type natriuretic peptide (BNP) is a hallmark in heart failure (HF). Diabetic patients with chronic HF seem to have higher BNP than nondiabetics. We studied, in acute HF, if BNP levels are different between diabetics and nondiabetics. METHODS: From a prospectively recruited pop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cunha, Filipe M., Pereira, Joana, Marques, Pedro, Moreira, Helena, Rodrigues, Pedro, Pinto, Maria João, Lourenço, Patrícia, Bettencourt, Paulo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592003/ https://www.ncbi.nlm.nih.gov/pubmed/28929118 http://dx.doi.org/10.1155/2017/1426705

Ejemplares similares

Towards a multi‐marker prognostic strategy in acute heart failure: a role for GDF‐15
por: Bettencourt, Paulo, et al.
Publicado: (2018)

Acute on chronic heart failure—Which variations on B‐type natriuretic peptide levels?
por: Bettencourt, Paulo, et al.
Publicado: (2021)

The prognostic impact of magnesium in acute heart failure is different according to the presence of diabetes mellitus
por: Cidade-Rodrigues, Catarina, et al.
Publicado: (2022)

Dynamics of growth differentiation factor 15 in acute heart failure
por: Lourenço, Patrícia, et al.
Publicado: (2021)

CA‐125 variation in acute heart failure: a single‐centre analysis
por: Lourenço, Patrícia, et al.
Publicado: (2022)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure?
por: Pereira, Joana, et al.
Publicado: (2018)

Influence of Spironolactone on Matrix Metalloproteinase-2 in Acute Decompensated Heart Failure
por: Ferreira, João Pedro, et al.
Publicado: (2015)

Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure?
por: Martín, Ernesto, et al.
Publicado: (2022)

High-Sensitivity Troponin T: A Biomarker for Diuretic Response in Decompensated Heart Failure Patients
por: Ferreira, João Pedro, et al.
Publicado: (2014)

Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches
por: Stienen, Susan, et al.
Publicado: (2020)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

Clinical Significance of B-type Natriuretic Peptide in Heart Failure
por: Yoo, Byung-Su
Publicado: (2014)

The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
por: Hamasaki, Hidetaka
Publicado: (2016)

B‐type natriuretic peptide‐guided treatment for heart failure
por: McLellan, Julie, et al.
Publicado: (2016)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

Levels of B-type natriuretic peptide in chronic heart failure patients with and without diabetes mellitus
por: PENG, QIANG, et al.
Publicado: (2013)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings
por: Tsai, Shih-Hung, et al.
Publicado: (2010)

Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure
por: Fu, Shihui, et al.
Publicado: (2018)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
por: Miyoshi, Takekazu, et al.
Publicado: (2021)

The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients
por: Marinescu, Mihai, et al.
Publicado: (2023)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

The value of multiparametric prediction scores in heart failure varies with the type of follow‐up after discharge: a comparative analysis
por: Rodrigues, Tiago, et al.
Publicado: (2023)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

The potential value of integrated natriuretic peptide and echo-guided heart failure management
por: Scali, Maria Chiara, et al.
Publicado: (2014)

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
por: Meijers, W. C., et al.
Publicado: (2016)

The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
por: Volpe, Massimo, et al.
Publicado: (2015)

Essential components in natriuretic peptide-guided management of heart failure: an intervention synthesis
por: Oke, Jason, et al.
Publicado: (2018)

The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan
por: Yandrapalli, Srikanth, et al.
Publicado: (2017)

Toward a New Paradigm for Targeted Natriuretic Peptide Enhancement in Heart Failure
por: Gidlöf, Olof
Publicado: (2021)

Cardiac congestion assessed by natriuretic peptides oversimplifies the definition and treatment of heart failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure
por: Alcidi, Gianmarco, et al.
Publicado: (2022)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin
por: Janovska, Petra, et al.
Publicado: (2020)

The Endocrine Function of the Heart: Physiology and Involvements of Natriuretic Peptides and Cyclic Nucleotide Phosphodiesterases in Heart Failure
por: Lugnier, Claire, et al.
Publicado: (2019)

Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_dgm46nsibvp7f3megjjirmen2t